HS
ELV icon

HighVista Strategies’s Elevance Health ELV Stock Holding History

HighVista Strategies’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,300
Closed -$1.44M – 157
2025
Q1 		$1.44M Buy
+3,300
New +$1.32M 0.55% 76
2024
Q4 		– Sell
-2,500
Closed -$1.3M – 151
2024
Q3 		$1.3M Buy
+2,500
New +$1.34M 0.45% 94
2024
Q1 		– Sell
-2,795
Closed -$1.32M – 137
2023
Q4 		$1.32M Buy
2,795
+1,395
+100% +$645K 0.48% 71
2023
Q3 		$610K Buy
+1,400
New +$635K 0.28% 84
2019
Q3 		– Sell
-1,800
Closed -$508K – 136
2019
Q2 		$508K Sell
1,800
-300
-14% -$81.9K 0.26% 64
2019
Q1 		$603K Buy
2,100
+1,200
+133% +$347K 0.49% 54
2018
Q4 		$236K Sell
900
-800
-47% -$220K 0.2% 87
2018
Q3 		$466K Buy
1,700
+300
+21% +$77.9K 0.22% 80
2018
Q2 		$333K Sell
1,400
-200
-13% -$46.3K 0.15% 108
2018
Q1 		$352K Buy
+1,600
New +$376K 0.15% 96
2017
Q4 		– Sell
-18,500
Closed -$3.51M – 232
2017
Q3 		$3.51M Buy
18,500
+2,300
+14% +$438K 0.8% 28
2017
Q2 		$3.05M Buy
+16,200
New +$2.91M 0.7% 36

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

HighVista Strategies's ELV Position: Q2 2025 in Review

HighVista Strategies sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 3,300 shares — an estimated $1.44M sold.

HighVista Strategies first reported a position in ELV in Q2 2017 and held it in 12 quarters. The position peaked at $3.51M in Q3 2017. 1,589 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

  • HighVista Strategies reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
  • HighVista Strategies sold 3,300 Elevance Health shares in Q2 2025, an estimated $1.44M.
  • HighVista Strategies first reported a position in Elevance Health in Q2 2017 and held it in 12 quarters.
  • HighVista Strategies's Elevance Health position peaked at $3.51M in Q3 2017.
  • 1,589 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on HighVista Strategies's 13F filing for Q2 2025, filed 14 Aug 2025.